Physician
Santa Rosa Medical Centers of Nevada, INC.
Santa Rosa Medical Centers of Nevada, INC. was paid $5.76M by Medicaid between Jan 2018 and Dec 2024, across 62 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 59% of everything it billed.
33Billing provider infoSANTA ROSA MEDICAL CENTERS OF NEVADA, INC.
LAS VEGAS, NV 89119
LAS VEGAS, NV 89119
33aNPI1912155110assigned 09/03/2008
33bProvider typeInternal Medicine Physician
28Total paid$5.76M
24GClaims103,207
24DCodes billed62
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in Nevada
Rank by total paid#7 of 465
Median peer was paid$35K
This provider vs. median165×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,251 | $104K | |
| 2019 | 9,134 | $602K | |
| 2020 | 6,048 | $433K | |
| 2021 | 6,094 | $405K | |
| 2022 | 23,080 | $1.42M | |
| 2023 | 32,360 | $1.48M | |
| 2024incomplete | 24,240 | $1.32M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 59% | 48,935 | 36,627 | $3.39M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 10% | 9,458 | 7,366 | $583K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 8.3% | 4,153 | 3,746 | $478K |
| 93978 | 3.2% | 1,607 | 1,453 | $184K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.3% | 6,133 | 5,035 | $134K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.1% | 1,469 | 1,363 | $119K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 2.1% | 1,079 | 955 | $118K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 1.9% | 1,100 | 992 | $110K |
| 93888 | 1.7% | 755 | 698 | $96K | |
| 93976 | 1.5% | 824 | 765 | $85K | |
| 93880 | 1.5% | 750 | 689 | $85K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1.0% | 571 | 513 | $58K |
50 more codes
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 401 | $40K |
| 76536 | <1% | 378 | $36K | |
| 99385 | <1% | 370 | $34K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 161 | $31K |
| 93000 | <1% | 2,258 | $24K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 222 | $23K |
| 99386 | <1% | 235 | $22K | |
| 93975 | <1% | 116 | $20K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 532 | $15K |
| 76770 | <1% | 244 | $9K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,901 | $8K |
| 92552 | <1% | 485 | $7K | |
| 93970 | <1% | 56 | $5K | |
| 93925 | <1% | 40 | $4K | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 423 | $4K |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 403 | $4K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 582 | $3K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 87 | $3K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 541 | $3K |
| 81002 | <1% | 2,514 | $3K | |
| 86769 | <1% | 830 | $3K | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,077 | $3K |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | <1% | 88 | $2K |
| 99406 | <1% | 297 | $2K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 14 | $2K |
| 96127 | <1% | 509 | $1K | |
| 71045 | Radiologic examination, chest; single view | <1% | 85 | $1K |
| 99408 | <1% | 190 | $1K | |
| 99401 | <1% | 117 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,726 | $985.21 |
| 81025 | <1% | 272 | $954.57 | |
| 72100 | <1% | 32 | $832.14 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,459 | $686.90 |
| 82948 | <1% | 508 | $617.07 | |
| 73560 | <1% | 17 | $605.56 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 44 | $542.15 |
| 85018 | <1% | 530 | $503.98 | |
| G2024 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source | <1% | 136 | $310.79 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 260 | $282.69 |
| 87070 | <1% | 58 | $141.69 | |
| H0049 | Alcohol and/or drug screening | <1% | 18 | $136.50 |
| 99177 | <1% | 32 | $90.31 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 110 | $81.23 |
| 97803 | <1% | 2,418 | $43.78 | |
| J0698 | Injection, cefotaxime sodium, per gm | <1% | 16 | $40.57 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 96 | $32.22 |
| 81005 | <1% | 41 | $30.33 | |
| G3003 | Each additional 15 minutes of chronic pain management and treatment by a physician or other qualified health care professional, per calendar month. (list separately in addition to code for g3002. when using g3003, 15 minutes must be met or exceeded.) | <1% | 106 | $10.06 |
| 99000 | 0% | 401 | $0.00 | |
| 99173 | 0% | 937 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPERVAIZ, SYED (PRESIDENT)